24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
20/09/2018
UAB’s researchers awarded by ERC
14/09/2018
More than 8,600 foreign companies in Catalonia
06/09/2018
SMEs: a European call for access to synchrotrons
27/07/2018
ICMAB and ICN2 work on the batteries of the future
20/07/2018
Molecular mimicry does not mislead ALBA!
13/07/2018
How about olive pits to filter the air?!